Morgan Stanley Starts Myriad Genetics (MYGN) at Underweight
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $17.98 --0%
Rating Summary:
8 Buy, 15 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 1
Rating Summary:
8 Buy, 15 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 1
Join SI Premium – FREE
Morgan Stanley initiated coverage on Myriad Genetics (NASDAQ: MYGN) with an Underweight rating and a price target of $25.00.
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $34.89 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Upgrades Husqvarna AB (HUSQB:SS) to Buy
- DA Davidson Starts Napco Security Technologies, Inc. (NSSC) at Buy
- Morgan Stanley Assumes Harley-Davidson (HOG) at Overweight, 'Freshly Tuned Up with Open Road Ahead'
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
